Terns Pharmaceuticals, Inc.
General ticker "TERN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $467.3M (TTM average)
Terns Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 36.7%.
Estimated limits based on current volatility of 3.3%: low 26.28$, high 28.11$
Factors to consider:
- Total employees count: 66 (+43.5%) as of 2023
- Top business risk factors: Operational and conduct risks, Market competition, Labor/talent shortage/retention, Geopolitical risks, Market access challenges
- Current price 201.0% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.70$, 9.01$]
- 2025-12-31 to 2026-12-31 estimated range: [3.54$, 8.66$]
Financial Metrics affecting the TERN estimates:
- Positive: with PPE of -5.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -15.21 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Negative: negative Industry operating income (median)
- Positive: -4.48 < Investing cash flow per share per price, % of -2.70
Short-term TERN quotes
Long-term TERN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $62.03MM | $102.56MM | $101.87MM |
| Operating Income | $-62.03MM | $-102.56MM | $-101.87MM |
| Non-Operating Income | $2.04MM | $12.59MM | $13.28MM |
| R&D Expense | $39.62MM | $63.50MM | $70.11MM |
| Income(Loss) | $-59.99MM | $-89.97MM | $-88.59MM |
| Taxes | $0.36MM | $0.24MM | $0.26MM |
| Profit(Loss)* | $-60.34MM | $-90.21MM | $-88.85MM |
| Stockholders Equity | $276.94MM | $255.37MM | $345.87MM |
| Assets | $287.03MM | $268.52MM | $363.93MM |
| Operating Cash Flow | $-49.11MM | $-67.39MM | $-70.02MM |
| Capital expenditure | $0.28MM | $0.05MM | $0.04MM |
| Investing Cash Flow | $-22.27MM | $-37.99MM | $-12.41MM |
| Financing Cash Flow | $167.09MM | $41.95MM | $164.00MM |
| Earnings Per Share** | $-1.67 | $-1.27 | $-1.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.